Form 483

Aegle Nutrition LLC Form 483, 2019-03-25

FDA issued a Form 483 to Aegle Nutrition LLC on 2019-03-25 with 22 public-safe observations.

483· Form 483 issuedFoods & Cosmetics22 observations

Aegle Nutrition LLC · Carrollton, United States · Issued March 25, 2019

Overview

  • 22 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

25 Mar 2019
21 CFR 111.105(c)

Basis; in-process, component, specifications

Cited by Charles B Steinmiller

25 Mar 2019
21 CFR 111.105(c)

Basis; in-process, component, specifications

Cited by Charles B Steinmiller

25 Mar 2019
21 CFR 111.123(b)(2)

Quality control - batch, product specifications

Cited by Charles B Steinmiller

25 Mar 2019
21 CFR 111.210(h)(1)

Instructions; specifications; quality

Cited by Charles B Steinmiller

25 Mar 2019
21 CFR 111.27(b)

Instruments - calibration

Cited by Charles B Steinmiller

Inspected site

ANAegle Nutrition LLCCarrollton, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.453Cited across public-safe Form 483 observations4x
21 CFR 111.95(b)(2)Cited across public-safe Form 483 observations4x
21 CFR 111.105(c)Cited across public-safe Form 483 observations2x
21 CFR 111.123(b)(2)Cited across public-safe Form 483 observations2x
21 CFR 111.210(h)(1)Cited across public-safe Form 483 observations2x
21 CFR 111.27(b)Cited across public-safe Form 483 observations2x
21 CFR 114.10Cited across public-safe Form 483 observations2x
21 CFR 114.80(a)(1)Cited across public-safe Form 483 observations2x
21 CFR 114.83Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 22 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere